Feds Recommend Daily Pill to Prevent AIDS

Image: Feds Recommend Daily Pill to Prevent AIDS

Thursday, 15 May 2014 08:57 AM

By Elliot Jager

Share:
  Comment  |
   Contact Us  |
  Print  
|  A   A  
  Copy Shortlink
Federal health authorities are advocating that people at risk for HIV infection take a daily dose of Truvada to prevent AIDS, The New York Times reported.

The move is a reversal of policy by the Centers for Disease Control and Prevention, which had urged at-risk men to rely on condoms.

Health authorities have been unable to persuade men vulnerable to the virus to always use condoms. The rate of prophylactic use has steadily declined among gay men, while the number of HIV infections has persisted at 50,000 annually.

Public health educators have spent the past three decades urging the use of condoms to block HIV transmission. Still, the number of gay men who said they engaged in unprotected sex has risen by almost 20 percent, the Times reported.

While officially the new CDC policy calls for the use of both condoms and the pill, health experts are aware that many gay men will feel encouraged to shift completely away from condom use. This is expected to lead to an increase in venereal disease rates.

Public health experts have nevertheless concluded that the pill is the best way to stop the spread of AIDS.

"Making the perfect the enemy of the good is something we've got to get over," Dr. Anthony Fauci, one of the foremost AIDS experts in the country, told the Times. "I strongly support the CDC doing this."

Some 500,000 men are expected to seek prescriptions for Truvada which costs about $13,000 a year. The drug is covered by most insurers and by state Medicaid.

High-risk groups include homosexual men who engage in unprotected sex, heterosexuals with high-risk partners, and drug addicts who share needles.

For now, Truvada is the only pill approved by the Food and Drug Administration for AIDS prevention. The drug combines tenofovir and emtricitabine and is considered comparatively safe, the Times reported.

The protocol requires pre- and follow-up testing for those taking the medication.

Not everyone in the healthcare community supports the change in CDC policy. Michael Weinstein, president of the AIDS Healthcare Foundation, described Truvada as a "party drug" according to the Times.

He added that use of the pill would encourage condom-less sex and more STDs. He noted that many people who have HIV have never been tested for the disease.

"Finding those individuals and linking them into care and treatment would do far more to break the chain of new HIV infections" than switching policy away from condoms to a daily pill, he said, according to the Times.

Related Stories:


© 2014 Newsmax. All rights reserved.

Share:
  Comment  |
   Contact Us  |
  Print  
  Copy Shortlink
Around the Web
Join the Newsmax Community
Please review Community Guidelines before posting a comment.
>> Register to share your comments with the community.
>> Login if you are already a member.
blog comments powered by Disqus
 
Email:
Country
Zip Code:
Privacy: We never share your email.
 
Hot Topics
Follow Newsmax
Like us
on Facebook
Follow us
on Twitter
Add us
on Google Plus
Around the Web
Top Stories
You May Also Like

George Will: I Am a 'Low-Voltage Atheist'

Monday, 22 Sep 2014 23:54 PM

In a wide-ranging interview, Pulitzer Prize-winning writer George Will discusses baseball, politics, and his status as a . . .

Dick Morris: Obama Has Secret Agenda

Monday, 22 Sep 2014 22:53 PM

What is Obama's real end game?
Now, for the first time, noted political strategist Dick Morris reveals Obama's secr . . .

Ex-UN Ambassador Wallace: US Should Just Say It - We're at War

Monday, 22 Sep 2014 19:55 PM

The United States should stop going out of its way to avoid calling the military initiative against the Islamic State (I . . .

Most Commented

Newsmax, Moneynews, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, NewsmaxWorld, NewsmaxHealth, are trademarks of Newsmax Media, Inc.

 
NEWSMAX.COM
America's News Page
©  Newsmax Media, Inc.
All Rights Reserved